C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/665 (2006.01) A61K 51/08 (2006.01)
Patent
CA 2284581
The invention relates to a carrier substance for radionuclides used in the diagnosis and/or radiotherapy of somatostatin receptor-positive tumors or target cells. Said conjugate consists of somatostatin 14 agonists, lanreotide and a macrocyclic chelating agent former which forms stable chelates with metallic radionuclides in physiological conditions.
L'invention concerne une substance porteuse pour radionucléides servant au diagnostic et/ou à la radiothérapie de tumeurs positives ou de cellules cibles positives en ce qui concerne le récepteur de la somatostatine. Il s'agit d'un conjugué constitué d'agonistes de somatostatine 14 du lanréotide et d'un chélateur macrocyclique qui forme des chélates stables avec des radionucléides métalliques, dans des conditions physiologiques.
Angelberger Peter
Smith-Jones Peter
Virgolini Irene
Nycomed Imaging As
Perley-Robertson Hill & Mcdougall Llp
Virgolini Irene
LandOfFree
Radiolabelled somatostatin receptor ligands for diagnosis... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radiolabelled somatostatin receptor ligands for diagnosis..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiolabelled somatostatin receptor ligands for diagnosis... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1900243